

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.73009923 |
| 2 | vocalization behavior (GO:0071625) | 4.66967002 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.66613060 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.43671839 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.41599172 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.34040883 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.18081720 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.12179760 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.11471299 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.10908631 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.06629969 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.04891371 |
| 13 | protein localization to synapse (GO:0035418) | 4.04560601 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.04187587 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.99132170 |
| 16 | synaptic transmission, glutamatergic (GO:0035249) | 3.80535027 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.74809294 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.73616915 |
| 19 | glutamate secretion (GO:0014047) | 3.71997670 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.64665589 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 3.58762876 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.53049681 |
| 23 | exploration behavior (GO:0035640) | 3.52089357 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.51323528 |
| 25 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.47883886 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47863076 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.45909012 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.45686915 |
| 29 | long-term memory (GO:0007616) | 3.44186703 |
| 30 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.43814464 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 3.43437733 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41510717 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.39967736 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39612575 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.36417079 |
| 36 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.35415461 |
| 37 | presynaptic membrane assembly (GO:0097105) | 3.31732880 |
| 38 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29790773 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.29227643 |
| 40 | cell communication by electrical coupling (GO:0010644) | 3.29206155 |
| 41 | membrane depolarization during action potential (GO:0086010) | 3.29180990 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.25075852 |
| 43 | proline transport (GO:0015824) | 3.24839087 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.23939882 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21962832 |
| 46 | cellular potassium ion homeostasis (GO:0030007) | 3.21959798 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.18732582 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 3.17724737 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.14659119 |
| 50 | cellular response to epinephrine stimulus (GO:0071872) | 3.13374990 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.09898253 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.09183884 |
| 53 | membrane depolarization (GO:0051899) | 3.05592878 |
| 54 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.04773931 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04065802 |
| 56 | layer formation in cerebral cortex (GO:0021819) | 3.03628810 |
| 57 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.02672810 |
| 58 | startle response (GO:0001964) | 3.02235475 |
| 59 | myofibril assembly (GO:0030239) | 3.01999186 |
| 60 | presynaptic membrane organization (GO:0097090) | 3.01607123 |
| 61 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.01163609 |
| 62 | detection of calcium ion (GO:0005513) | 3.01131846 |
| 63 | neuron recognition (GO:0008038) | 3.00823197 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.99963808 |
| 65 | nerve growth factor signaling pathway (GO:0038180) | 2.98070235 |
| 66 | response to epinephrine (GO:0071871) | 2.96787076 |
| 67 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95857344 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 2.92977772 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90384145 |
| 70 | regulation of neurotransmitter secretion (GO:0046928) | 2.90083983 |
| 71 | auditory behavior (GO:0031223) | 2.88993691 |
| 72 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.87352395 |
| 73 | membrane hyperpolarization (GO:0060081) | 2.86683697 |
| 74 | regulation of relaxation of muscle (GO:1901077) | 2.86630961 |
| 75 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86141207 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 2.85018813 |
| 77 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.84206538 |
| 78 | regulation of vesicle fusion (GO:0031338) | 2.83144524 |
| 79 | response to auditory stimulus (GO:0010996) | 2.82912395 |
| 80 | negative regulation of cell killing (GO:0031342) | 2.82833148 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82833148 |
| 82 | microglial cell activation (GO:0001774) | 2.81642536 |
| 83 | dendrite morphogenesis (GO:0048813) | 2.81551690 |
| 84 | long-term synaptic potentiation (GO:0060291) | 2.79986716 |
| 85 | synapse assembly (GO:0007416) | 2.78979392 |
| 86 | axonal fasciculation (GO:0007413) | 2.77796597 |
| 87 | L-amino acid import (GO:0043092) | 2.76930458 |
| 88 | neurotransmitter transport (GO:0006836) | 2.76800556 |
| 89 | regulation of membrane repolarization (GO:0060306) | 2.75498012 |
| 90 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.75228388 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.74424533 |
| 92 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74151020 |
| 93 | cardiac myofibril assembly (GO:0055003) | 2.73808523 |
| 94 | glycine transport (GO:0015816) | 2.73755148 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.73469872 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 2.73384493 |
| 97 | striatum development (GO:0021756) | 2.72334807 |
| 98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70948400 |
| 99 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.70471307 |
| 100 | learning (GO:0007612) | 2.69895198 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68653223 |
| 102 | innervation (GO:0060384) | 2.68457925 |
| 103 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.68361121 |
| 104 | sodium ion export (GO:0071436) | 2.68220725 |
| 105 | adult walking behavior (GO:0007628) | 2.67589336 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.67305617 |
| 107 | regulation of dendritic spine development (GO:0060998) | 2.67223959 |
| 108 | cellular extravasation (GO:0045123) | 2.67034758 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 2.66433810 |
| 110 | positive regulation of synapse maturation (GO:0090129) | 2.65410846 |
| 111 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.64254263 |
| 112 | regulation of actin filament-based movement (GO:1903115) | 2.64037587 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 2.62390712 |
| 114 | multicellular organismal signaling (GO:0035637) | 2.62292017 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.62190634 |
| 116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61926056 |
| 117 | cardiac muscle hypertrophy (GO:0003300) | 2.61315192 |
| 118 | response to histamine (GO:0034776) | 2.60370070 |
| 119 | neutrophil mediated immunity (GO:0002446) | 2.57507778 |
| 120 | relaxation of cardiac muscle (GO:0055119) | 2.57295464 |
| 121 | cardiac muscle contraction (GO:0060048) | 2.56870897 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56643530 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.54668705 |
| 124 | striated muscle hypertrophy (GO:0014897) | 2.54237994 |
| 125 | muscle filament sliding (GO:0030049) | 2.45997867 |
| 126 | actin-myosin filament sliding (GO:0033275) | 2.45997867 |
| 127 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45340317 |
| 128 | macrophage activation involved in immune response (GO:0002281) | 2.44448825 |
| 129 | cellular response to catecholamine stimulus (GO:0071870) | 2.42032494 |
| 130 | cellular response to monoamine stimulus (GO:0071868) | 2.42032494 |
| 131 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39604626 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.37434983 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.37434983 |
| 134 | macrophage activation (GO:0042116) | 2.36811360 |
| 135 | regulation of striated muscle contraction (GO:0006942) | 2.35898993 |
| 136 | response to catecholamine (GO:0071869) | 2.34969519 |
| 137 | response to monoamine (GO:0071867) | 2.34969519 |
| 138 | interkinetic nuclear migration (GO:0022027) | 2.34347153 |
| 139 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33062475 |
| 140 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33062475 |
| 141 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33062475 |
| 142 | modulation by symbiont of host immune response (GO:0052553) | 2.33062475 |
| 143 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33062475 |
| 144 | modulation by symbiont of host defense response (GO:0052031) | 2.33062475 |
| 145 | macroautophagy (GO:0016236) | 2.32721170 |
| 146 | regulation of beta-amyloid formation (GO:1902003) | 2.31317723 |
| 147 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30477852 |
| 148 | muscle hypertrophy (GO:0014896) | 2.29683757 |
| 149 | positive regulation of cation channel activity (GO:2001259) | 2.27602153 |
| 150 | myeloid leukocyte mediated immunity (GO:0002444) | 2.27462864 |
| 151 | regulation of Rap GTPase activity (GO:0032317) | 2.26907783 |
| 152 | potassium ion import (GO:0010107) | 2.26473740 |
| 153 | nucleus localization (GO:0051647) | 2.26395232 |
| 154 | cellular response to ethanol (GO:0071361) | 2.24208802 |
| 155 | activated T cell proliferation (GO:0050798) | 2.23673871 |
| 156 | establishment of protein localization to Golgi (GO:0072600) | 2.23575104 |
| 157 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.22889834 |
| 158 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22513753 |
| 159 | regulation of cardiac muscle contraction (GO:0055117) | 2.22432935 |
| 160 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.21954169 |
| 161 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.21820960 |
| 162 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.20081368 |
| 163 | urinary tract smooth muscle contraction (GO:0014848) | 2.19919973 |
| 164 | striated muscle contraction (GO:0006941) | 2.17105925 |
| 165 | sarcomere organization (GO:0045214) | 2.16670771 |
| 166 | positive regulation of phosphatase activity (GO:0010922) | 2.16504607 |
| 167 | regulation of sarcomere organization (GO:0060297) | 2.15766194 |
| 168 | skeletal muscle adaptation (GO:0043501) | 2.15630444 |
| 169 | regulation of skeletal muscle contraction (GO:0014819) | 2.14600918 |
| 170 | response to inactivity (GO:0014854) | 2.14294163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.30864773 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.03919325 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83689518 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75943539 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74317881 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43824640 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43824640 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36907289 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.34276707 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31301491 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28842129 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27355340 |
| 13 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21869036 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20753368 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17336467 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14216388 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11816120 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97682562 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97014774 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96786935 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92499928 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89148939 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86719794 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86068995 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85492055 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84199207 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83293924 |
| 28 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80233006 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77493247 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.75756694 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74267078 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71045068 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70574008 |
| 34 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70307144 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68514190 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64893844 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62239775 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58450330 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55608582 |
| 40 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54798788 |
| 41 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.53228349 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52564162 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49836903 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46915431 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45275717 |
| 46 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42141529 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41617748 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41086102 |
| 49 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40635784 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38892509 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37835405 |
| 52 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36748538 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35739579 |
| 54 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34641738 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34591475 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34551311 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34338294 |
| 58 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34195407 |
| 59 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32481152 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30947685 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30410758 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29883035 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29516417 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28488525 |
| 65 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28064797 |
| 66 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27948432 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27567696 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27094440 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26646121 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24118601 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24114353 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21589821 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20173682 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19679715 |
| 75 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16522472 |
| 76 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16137470 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15475990 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13990928 |
| 79 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13972956 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13480207 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12891683 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12486358 |
| 83 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12267772 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12063611 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11393227 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11153181 |
| 87 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11031873 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09901718 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09692773 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09656851 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09300211 |
| 92 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09290467 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09278090 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08022608 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07226552 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06732362 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06732362 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06460288 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05046031 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04984528 |
| 101 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04829755 |
| 102 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04829755 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04823048 |
| 104 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03734519 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03694224 |
| 106 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03687046 |
| 107 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03001628 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02279025 |
| 109 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01883257 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01327237 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00315560 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99337685 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98886110 |
| 114 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98854169 |
| 115 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.98500905 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98439671 |
| 117 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98423694 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97635344 |
| 119 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97612764 |
| 120 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97423882 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97348287 |
| 122 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97119885 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96949830 |
| 124 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96246866 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95735560 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94545452 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94233676 |
| 128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93243581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.19823903 |
| 2 | MP0003880_abnormal_central_pattern | 4.04841600 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.50427542 |
| 4 | MP0004270_analgesia | 3.29252476 |
| 5 | MP0009046_muscle_twitch | 3.01024891 |
| 6 | MP0009745_abnormal_behavioral_response | 3.00024792 |
| 7 | MP0003724_increased_susceptibility_to | 2.88285134 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.77278250 |
| 9 | MP0002064_seizures | 2.65355662 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.57471185 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.57229338 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.53182793 |
| 13 | MP0001486_abnormal_startle_reflex | 2.50533864 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.49433066 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.46400043 |
| 16 | MP0002272_abnormal_nervous_system | 2.41721516 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.32514259 |
| 18 | MP0002822_catalepsy | 2.09604309 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.97826322 |
| 20 | MP0001188_hyperpigmentation | 1.95817665 |
| 21 | MP0003828_pulmonary_edema | 1.94960659 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.94873876 |
| 23 | MP0002736_abnormal_nociception_after | 1.94152954 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.92623015 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.90385916 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.88078789 |
| 27 | MP0003787_abnormal_imprinting | 1.87950205 |
| 28 | MP0000751_myopathy | 1.86946761 |
| 29 | MP0008569_lethality_at_weaning | 1.84320433 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.80671681 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.80565705 |
| 32 | MP0001970_abnormal_pain_threshold | 1.78235308 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.76432496 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.75412965 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.71498068 |
| 36 | MP0003303_peritoneal_inflammation | 1.71465830 |
| 37 | MP0004924_abnormal_behavior | 1.67667446 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.67667446 |
| 39 | MP0002184_abnormal_innervation | 1.66600071 |
| 40 | MP0001984_abnormal_olfaction | 1.65756729 |
| 41 | MP0000778_abnormal_nervous_system | 1.60064841 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.57266281 |
| 43 | MP0003646_muscle_fatigue | 1.53220737 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.47728951 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.33210239 |
| 46 | MP0003879_abnormal_hair_cell | 1.30646523 |
| 47 | MP0004142_abnormal_muscle_tone | 1.29565200 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.27882258 |
| 49 | MP0005409_darkened_coat_color | 1.27535848 |
| 50 | MP0004484_altered_response_of | 1.27363730 |
| 51 | MP0000955_abnormal_spinal_cord | 1.27320967 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.26411671 |
| 53 | MP0004858_abnormal_nervous_system | 1.25472964 |
| 54 | MP0003633_abnormal_nervous_system | 1.25442859 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.25179842 |
| 56 | MP0004085_abnormal_heartbeat | 1.24006804 |
| 57 | MP0005670_abnormal_white_adipose | 1.23785028 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.22302978 |
| 59 | MP0003137_abnormal_impulse_conducting | 1.21618182 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.21448899 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.21221189 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.18045935 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.13176649 |
| 64 | MP0003122_maternal_imprinting | 1.10496786 |
| 65 | MP0001905_abnormal_dopamine_level | 1.07534845 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.06913539 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.06832186 |
| 68 | MP0003690_abnormal_glial_cell | 1.06706662 |
| 69 | MP0003045_fibrosis | 1.06340202 |
| 70 | MP0005171_absent_coat_pigmentation | 1.05310101 |
| 71 | MP0004130_abnormal_muscle_cell | 1.03566757 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.03467240 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.02667374 |
| 74 | MP0004742_abnormal_vestibular_system | 1.02561459 |
| 75 | MP0004883_abnormal_blood_vessel | 1.02266203 |
| 76 | MP0005620_abnormal_muscle_contractility | 1.01241515 |
| 77 | MP0005385_cardiovascular_system_phenoty | 1.01136012 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 1.01136012 |
| 79 | MP0005369_muscle_phenotype | 1.00746301 |
| 80 | MP0003631_nervous_system_phenotype | 1.00581382 |
| 81 | MP0002009_preneoplasia | 1.00200956 |
| 82 | MP0001958_emphysema | 0.99087191 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.98837835 |
| 84 | MP0000749_muscle_degeneration | 0.97453751 |
| 85 | MP0004036_abnormal_muscle_relaxation | 0.97357676 |
| 86 | MP0004885_abnormal_endolymph | 0.95834764 |
| 87 | MP0005535_abnormal_body_temperature | 0.92921888 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.92526432 |
| 89 | MP0004510_myositis | 0.91961754 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.91959935 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.91331084 |
| 92 | MP0001529_abnormal_vocalization | 0.90827995 |
| 93 | MP0002229_neurodegeneration | 0.87532330 |
| 94 | MP0002972_abnormal_cardiac_muscle | 0.87282597 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.86009139 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.85638817 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85441890 |
| 98 | MP0002419_abnormal_innate_immunity | 0.85288746 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.85230827 |
| 100 | MP0001177_atelectasis | 0.85075496 |
| 101 | MP0002152_abnormal_brain_morphology | 0.84860795 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.84825207 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.83980721 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.83757450 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.83495805 |
| 106 | MP0000747_muscle_weakness | 0.81010896 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.80844549 |
| 108 | MP0002269_muscular_atrophy | 0.79311825 |
| 109 | MP0000604_amyloidosis | 0.79243860 |
| 110 | MP0004381_abnormal_hair_follicle | 0.78780781 |
| 111 | MP0003329_amyloid_beta_deposits | 0.78299606 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.77774162 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.77555338 |
| 114 | MP0003436_decreased_susceptibility_to | 0.77434027 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.77105872 |
| 116 | MP0003632_abnormal_nervous_system | 0.76923536 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.75697775 |
| 118 | MP0002069_abnormal_eating/drinking_beha | 0.74860899 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.73607838 |
| 120 | MP0002133_abnormal_respiratory_system | 0.71872266 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.70790721 |
| 122 | MP0003634_abnormal_glial_cell | 0.69835668 |
| 123 | MP0005330_cardiomyopathy | 0.69649283 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.69543756 |
| 125 | MP0008874_decreased_physiological_sensi | 0.68859469 |
| 126 | MP0000920_abnormal_myelination | 0.67486945 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.63168198 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.63146886 |
| 129 | MP0008872_abnormal_physiological_respon | 0.61229697 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.61152263 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.61023844 |
| 132 | MP0006138_congestive_heart_failure | 0.59884991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.04937256 |
| 2 | Focal seizures (HP:0007359) | 5.13338891 |
| 3 | Myokymia (HP:0002411) | 5.02345983 |
| 4 | Febrile seizures (HP:0002373) | 4.96958510 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.49195085 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.29455515 |
| 7 | Broad-based gait (HP:0002136) | 4.05680442 |
| 8 | Atonic seizures (HP:0010819) | 4.01887488 |
| 9 | Visual hallucinations (HP:0002367) | 3.84234151 |
| 10 | Action tremor (HP:0002345) | 3.68092244 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 3.56354766 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 3.49579023 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.47851384 |
| 14 | Difficulty running (HP:0009046) | 3.46184544 |
| 15 | Absence seizures (HP:0002121) | 3.42938995 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.41865583 |
| 17 | Dialeptic seizures (HP:0011146) | 3.20020648 |
| 18 | Prolonged QT interval (HP:0001657) | 3.12807586 |
| 19 | Sudden death (HP:0001699) | 3.00774473 |
| 20 | Dysdiadochokinesis (HP:0002075) | 2.90000275 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.89810832 |
| 22 | Subaortic stenosis (HP:0001682) | 2.89810832 |
| 23 | Atrial fibrillation (HP:0005110) | 2.87811699 |
| 24 | Hyperventilation (HP:0002883) | 2.86119006 |
| 25 | Poor eye contact (HP:0000817) | 2.83021716 |
| 26 | Optic neuritis (HP:0100653) | 2.80738375 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.80738375 |
| 28 | Abnormal EKG (HP:0003115) | 2.78555197 |
| 29 | Syncope (HP:0001279) | 2.78356454 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 2.77933046 |
| 31 | Muscle fiber inclusion bodies (HP:0100299) | 2.75078884 |
| 32 | Hemiparesis (HP:0001269) | 2.73628320 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.71547450 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.68582145 |
| 35 | Truncal ataxia (HP:0002078) | 2.68345976 |
| 36 | Myositis (HP:0100614) | 2.67623689 |
| 37 | Genetic anticipation (HP:0003743) | 2.66574609 |
| 38 | Dysmetria (HP:0001310) | 2.66324209 |
| 39 | Orchitis (HP:0100796) | 2.65914672 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.64504756 |
| 41 | Nemaline bodies (HP:0003798) | 2.62548700 |
| 42 | Postural instability (HP:0002172) | 2.61852398 |
| 43 | Drooling (HP:0002307) | 2.61426170 |
| 44 | Excessive salivation (HP:0003781) | 2.61426170 |
| 45 | Supraventricular tachycardia (HP:0004755) | 2.56356887 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.54208645 |
| 47 | Anxiety (HP:0000739) | 2.51253243 |
| 48 | Impaired social interactions (HP:0000735) | 2.49896713 |
| 49 | Abnormal social behavior (HP:0012433) | 2.49896713 |
| 50 | Supraventricular arrhythmia (HP:0005115) | 2.49643416 |
| 51 | Bradycardia (HP:0001662) | 2.49450748 |
| 52 | Fetal akinesia sequence (HP:0001989) | 2.49135123 |
| 53 | Amblyopia (HP:0000646) | 2.46581601 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 2.46537671 |
| 55 | Hemiplegia (HP:0002301) | 2.46298050 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.44955336 |
| 57 | Abnormal eating behavior (HP:0100738) | 2.43554111 |
| 58 | Ventricular tachycardia (HP:0004756) | 2.43225509 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43223946 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.43158223 |
| 61 | Frequent falls (HP:0002359) | 2.42952427 |
| 62 | Abnormality of binocular vision (HP:0011514) | 2.40669257 |
| 63 | Diplopia (HP:0000651) | 2.40669257 |
| 64 | Mutism (HP:0002300) | 2.38860905 |
| 65 | Scanning speech (HP:0002168) | 2.38309257 |
| 66 | Depression (HP:0000716) | 2.36493441 |
| 67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.35946716 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.35740203 |
| 69 | Absent speech (HP:0001344) | 2.34965075 |
| 70 | EMG: myopathic abnormalities (HP:0003458) | 2.34029578 |
| 71 | Calf muscle hypertrophy (HP:0008981) | 2.33857387 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.30901642 |
| 73 | Ankle clonus (HP:0011448) | 2.30375449 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.30346714 |
| 75 | Bundle branch block (HP:0011710) | 2.30025993 |
| 76 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.26700077 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.26473121 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.23304516 |
| 79 | Dysmetric saccades (HP:0000641) | 2.21884117 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21831397 |
| 81 | Exercise-induced myalgia (HP:0003738) | 2.21440026 |
| 82 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21357220 |
| 83 | Aplasia involving bones of the extremities (HP:0009825) | 2.17015611 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.17015611 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.17015611 |
| 86 | Abnormality of the calf musculature (HP:0001430) | 2.16142027 |
| 87 | Protruding tongue (HP:0010808) | 2.14273615 |
| 88 | Aortic aneurysm (HP:0004942) | 2.13826044 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.13171078 |
| 90 | Peritonitis (HP:0002586) | 2.12236050 |
| 91 | Stomatitis (HP:0010280) | 2.07847306 |
| 92 | Heart block (HP:0012722) | 2.05853751 |
| 93 | Abnormal hair whorl (HP:0010721) | 2.05352080 |
| 94 | Progressive inability to walk (HP:0002505) | 2.04792914 |
| 95 | Epileptiform EEG discharges (HP:0011182) | 2.03255367 |
| 96 | Central scotoma (HP:0000603) | 2.01863151 |
| 97 | Obstructive sleep apnea (HP:0002870) | 1.99781460 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 1.99298084 |
| 99 | Incomplete penetrance (HP:0003829) | 1.98695306 |
| 100 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97619896 |
| 101 | Facial diplegia (HP:0001349) | 1.94359736 |
| 102 | Keratoconjunctivitis (HP:0001096) | 1.94357296 |
| 103 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.93777289 |
| 104 | Stereotypic behavior (HP:0000733) | 1.93772673 |
| 105 | Aqueductal stenosis (HP:0002410) | 1.93234369 |
| 106 | Papillary thyroid carcinoma (HP:0002895) | 1.90452137 |
| 107 | Abnormality of salivation (HP:0100755) | 1.89924289 |
| 108 | Chest pain (HP:0100749) | 1.89528133 |
| 109 | Spastic gait (HP:0002064) | 1.89271061 |
| 110 | Vertigo (HP:0002321) | 1.89185704 |
| 111 | Hypochromic microcytic anemia (HP:0004840) | 1.88594245 |
| 112 | Pheochromocytoma (HP:0002666) | 1.88037050 |
| 113 | Intention tremor (HP:0002080) | 1.87618107 |
| 114 | Lipoatrophy (HP:0100578) | 1.87557496 |
| 115 | Lower limb muscle weakness (HP:0007340) | 1.87398604 |
| 116 | Gingivitis (HP:0000230) | 1.86377085 |
| 117 | Myotonia (HP:0002486) | 1.85526421 |
| 118 | EEG with generalized epileptiform discharges (HP:0011198) | 1.85484865 |
| 119 | Inability to walk (HP:0002540) | 1.84964030 |
| 120 | Bradykinesia (HP:0002067) | 1.83172890 |
| 121 | Blue irides (HP:0000635) | 1.83111254 |
| 122 | Hematochezia (HP:0002573) | 1.82553249 |
| 123 | Abnormality of the endocardium (HP:0004306) | 1.81852732 |
| 124 | Abnormality of the foot musculature (HP:0001436) | 1.81229045 |
| 125 | Hemoptysis (HP:0002105) | 1.81211082 |
| 126 | Exotropia (HP:0000577) | 1.80826986 |
| 127 | Limb dystonia (HP:0002451) | 1.80390725 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.78158258 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 1.77618118 |
| 130 | Ventricular arrhythmia (HP:0004308) | 1.77131572 |
| 131 | Papilledema (HP:0001085) | 1.77056619 |
| 132 | Polyphagia (HP:0002591) | 1.76822885 |
| 133 | Hyperkalemia (HP:0002153) | 1.76685131 |
| 134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76210450 |
| 135 | Neoplasm of the heart (HP:0100544) | 1.75798092 |
| 136 | Distal arthrogryposis (HP:0005684) | 1.75664411 |
| 137 | Abnormal atrioventricular conduction (HP:0005150) | 1.73853219 |
| 138 | Gingival bleeding (HP:0000225) | 1.72376727 |
| 139 | Retinal dysplasia (HP:0007973) | 1.70284781 |
| 140 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69203995 |
| 141 | Absent/shortened dynein arms (HP:0200106) | 1.69203995 |
| 142 | Steppage gait (HP:0003376) | 1.69178479 |
| 143 | Distal lower limb amyotrophy (HP:0008944) | 1.66659625 |
| 144 | Deeply set eye (HP:0000490) | 1.66620673 |
| 145 | Hypsarrhythmia (HP:0002521) | 1.66166874 |
| 146 | Urinary urgency (HP:0000012) | 1.65513960 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.64692295 |
| 148 | Left ventricular hypertrophy (HP:0001712) | 1.64662015 |
| 149 | Generalized hypopigmentation of hair (HP:0011358) | 1.64608028 |
| 150 | Widely spaced teeth (HP:0000687) | 1.63850949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.50795396 |
| 2 | EPHA4 | 3.38534550 |
| 3 | CASK | 3.09057989 |
| 4 | MARK1 | 3.06618635 |
| 5 | FRK | 3.03389970 |
| 6 | MAP2K7 | 2.55632673 |
| 7 | TNIK | 2.44099437 |
| 8 | MAP3K4 | 2.43257133 |
| 9 | MAP3K9 | 2.17957227 |
| 10 | PRPF4B | 2.11110035 |
| 11 | MINK1 | 2.04146962 |
| 12 | NTRK2 | 1.98639405 |
| 13 | RIPK4 | 1.86772364 |
| 14 | DAPK2 | 1.86362989 |
| 15 | BLK | 1.77545633 |
| 16 | MAPK13 | 1.75315543 |
| 17 | PHKG2 | 1.74201175 |
| 18 | PHKG1 | 1.74201175 |
| 19 | INSRR | 1.64414570 |
| 20 | PIK3CG | 1.62166689 |
| 21 | SGK2 | 1.48311573 |
| 22 | MAP3K12 | 1.47428648 |
| 23 | CAMK1G | 1.46002195 |
| 24 | STK38 | 1.43288294 |
| 25 | PAK6 | 1.43181101 |
| 26 | CDK5 | 1.33273185 |
| 27 | MAP2K4 | 1.32538109 |
| 28 | GRK5 | 1.24644900 |
| 29 | SGK223 | 1.22974922 |
| 30 | SGK494 | 1.22974922 |
| 31 | PLK2 | 1.22377888 |
| 32 | PRKD3 | 1.20956435 |
| 33 | PINK1 | 1.19822743 |
| 34 | LMTK2 | 1.19260087 |
| 35 | TTN | 1.18688148 |
| 36 | MUSK | 1.17515989 |
| 37 | CAMKK2 | 1.15430257 |
| 38 | SIK2 | 1.14415145 |
| 39 | CAMKK1 | 1.14076301 |
| 40 | CAMK2A | 1.13723959 |
| 41 | FGFR3 | 1.12420150 |
| 42 | CAMK1 | 1.12220243 |
| 43 | MAP2K3 | 1.12058119 |
| 44 | NEK6 | 1.10337088 |
| 45 | PRKCG | 1.09372115 |
| 46 | SGK3 | 1.08073815 |
| 47 | NTRK1 | 1.07739930 |
| 48 | TAOK3 | 1.06815392 |
| 49 | EPHA3 | 1.06398802 |
| 50 | FES | 1.04683019 |
| 51 | CAMK1D | 1.03554385 |
| 52 | AKT3 | 1.03066162 |
| 53 | DMPK | 1.01624637 |
| 54 | PNCK | 1.00909409 |
| 55 | GRK7 | 1.00118361 |
| 56 | IRAK1 | 0.97048224 |
| 57 | SYK | 0.96917221 |
| 58 | MARK2 | 0.95638111 |
| 59 | SGK1 | 0.95503988 |
| 60 | TRPM7 | 0.94903319 |
| 61 | DAPK1 | 0.94071592 |
| 62 | BMPR2 | 0.93833618 |
| 63 | TXK | 0.91798026 |
| 64 | PRKCE | 0.90852516 |
| 65 | OBSCN | 0.90257730 |
| 66 | CSK | 0.89117045 |
| 67 | JAK1 | 0.88172772 |
| 68 | KSR1 | 0.86493996 |
| 69 | SIK3 | 0.85164296 |
| 70 | STK11 | 0.84167509 |
| 71 | JAK2 | 0.84127249 |
| 72 | NLK | 0.83917059 |
| 73 | PRKCH | 0.82914863 |
| 74 | IRAK4 | 0.81857322 |
| 75 | EPHB1 | 0.81287564 |
| 76 | CDC42BPA | 0.80746567 |
| 77 | CAMK2B | 0.80241686 |
| 78 | HCK | 0.79199640 |
| 79 | TGFBR2 | 0.78953762 |
| 80 | TNK2 | 0.78688150 |
| 81 | TEC | 0.76735414 |
| 82 | CAMK2D | 0.76564349 |
| 83 | TYK2 | 0.75662071 |
| 84 | KIT | 0.74619798 |
| 85 | TAOK1 | 0.74204956 |
| 86 | MAP3K1 | 0.73722010 |
| 87 | WNK1 | 0.72081588 |
| 88 | GRK6 | 0.72067812 |
| 89 | ZAP70 | 0.70531564 |
| 90 | MAP3K2 | 0.69928109 |
| 91 | MAPK12 | 0.68721227 |
| 92 | UHMK1 | 0.68512232 |
| 93 | PKN1 | 0.68440011 |
| 94 | MAP3K5 | 0.68299579 |
| 95 | PTK2B | 0.68285247 |
| 96 | RET | 0.67386460 |
| 97 | ITK | 0.66861989 |
| 98 | IKBKE | 0.65645304 |
| 99 | PIK3CA | 0.65461309 |
| 100 | TIE1 | 0.65137680 |
| 101 | CAMK4 | 0.64449292 |
| 102 | PRKD1 | 0.62973819 |
| 103 | DYRK1A | 0.61299051 |
| 104 | FGR | 0.60711429 |
| 105 | MAP3K13 | 0.60636371 |
| 106 | CDK3 | 0.59388625 |
| 107 | BTK | 0.59030377 |
| 108 | MAP2K6 | 0.58513265 |
| 109 | FGFR2 | 0.58174414 |
| 110 | KSR2 | 0.57214138 |
| 111 | OXSR1 | 0.55953738 |
| 112 | PAK3 | 0.55929151 |
| 113 | RPS6KA3 | 0.52798706 |
| 114 | MAP3K6 | 0.49894873 |
| 115 | PRKG1 | 0.49402821 |
| 116 | PDK1 | 0.47702028 |
| 117 | MAPK7 | 0.47641781 |
| 118 | RIPK1 | 0.47154219 |
| 119 | CDK19 | 0.47071877 |
| 120 | PDPK1 | 0.46804700 |
| 121 | CSNK1G2 | 0.46254444 |
| 122 | PRKACA | 0.45688233 |
| 123 | CAMK2G | 0.45596370 |
| 124 | MAPK10 | 0.45550146 |
| 125 | BCR | 0.44559048 |
| 126 | MYLK | 0.43284550 |
| 127 | FER | 0.42766888 |
| 128 | PRKAA2 | 0.42157685 |
| 129 | GRK1 | 0.40724334 |
| 130 | PRKAA1 | 0.40026053 |
| 131 | ROCK1 | 0.39794446 |
| 132 | PRKCZ | 0.39395210 |
| 133 | IRAK2 | 0.37818655 |
| 134 | LATS2 | 0.37522756 |
| 135 | FYN | 0.37081635 |
| 136 | MAP3K7 | 0.36806613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51955782 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.64793661 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.57501559 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.55692618 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.50805206 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50454393 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41169941 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.36681282 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.32740862 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.17011673 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.09712078 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.01320260 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.98921389 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87602832 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.87177300 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83132775 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.82605228 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.78539545 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72909623 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71985409 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67378066 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65618162 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61904089 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.59097683 |
| 25 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.45809857 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45635540 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42566136 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.38353111 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.34774470 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34322591 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32102885 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30725851 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29307736 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28462192 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26363690 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23266608 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.20109491 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16747294 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16062319 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.15552055 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.10930325 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09303949 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04741173 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03707294 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02969215 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01257142 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00425411 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.00141505 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96543362 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.96138077 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95120989 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93144528 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92391454 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89517343 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89004377 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83546395 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82170063 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.82005616 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.81855291 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.81561882 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80826167 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80692372 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80217323 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78325006 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77326650 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75940571 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74461627 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74018173 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73958654 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72841160 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72057639 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71357579 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70489682 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70241913 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70145009 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70051353 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67308646 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.67265016 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66835591 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66618195 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65353885 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64955942 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64682982 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64153131 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63266812 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60262022 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60068935 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59897255 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59207811 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58204482 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.57653419 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.57421651 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.57196643 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57026643 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56900311 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56193087 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56014879 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55868450 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55538201 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55460692 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54269442 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52691949 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49311212 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48936703 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48539942 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47051547 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46851337 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46788453 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45405361 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45257103 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40136207 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37470642 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35823713 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35608995 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.35481440 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.34612683 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33531725 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33205667 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31057303 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30380981 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30290889 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29816689 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29371450 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.28505836 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27114072 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27026169 |

